NCT02151656View on ClinicalTrials.gov

F17464 in Acute Schizophrenia Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

158

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Schizophrenia

Interventions

DRUG

F17464

DRUG

Placebo

Trial Locations (27)

Unknown

Nîmes

Sotteville-lès-Rouen

Balassagyarmat

Budapest

Gyula

Daugavpils

Jelgava

Liepāja

Strenči

Arad

Bucharest

Campulum G Muscel

Craiova

Galati

Iași

Sibiu

Târgovişte

Târgu Mureş

Timișoara

Arkhangelsky District

Engel's

Kazan'

Moscow

Orenburg

Saratov

Tomsk

Yekaterinburg

All Listed Sponsors

lead

Pierre Fabre Medicament

INDUSTRY

NCT02151656 - F17464 in Acute Schizophrenia Trial | Biotech Hunter | Biotech Hunter